This page is part of the HL7 Europe Laboratory Report (v0.1.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
<Observation xmlns="http://hl7.org/fhir">
<id value="obs-org-id1-susc-2"/>
<meta>
<profile
value="http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Observation</b><a name="obs-org-id1-susc-2"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Observation "obs-org-id1-susc-2" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Observation-resultslab-eu-lab.html">Observation Results: laboratory</a></p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-observation-category.html">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: levoFLOXacin [Susceptibility] <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#20629-2)</span></p><p><b>subject</b>: <a href="Patient-pat-lab-example.html">Patient/pat-lab-example</a> " OČKOVANÝ MOREIRA"</p><p><b>effective</b>: 2022-10-25 13:35:00+0100</p><p><b>performer</b>: <span>: MUDr. Aleš Procházka</span></p><p><b>value</b>: >4 1<span style="background: LightGoldenRodYellow"> (Details: UCUM code 1 = '1')</span></p><p><b>interpretation</b>: Resistant <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ObservationInterpretation.html">ObservationInterpretation</a>#R)</span></p></div>
</text>
<status value="final"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/observation-category"/>
<code value="laboratory"/>
</coding>
</category>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="20629-2"/>
<display value="levoFLOXacin [Susceptibility]"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/pat-lab-example"/>
</subject>
<effectiveDateTime value="2022-10-25T13:35:00+01:00"/>
<performer>
<display value="MUDr. Aleš Procházka"/>
</performer>
<valueQuantity>
<value value="4"/>
<comparator value=">"/>
<system value="http://unitsofmeasure.org"/>
<code value="1"/>
</valueQuantity>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>